Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.050
0.00 (0.00%)
May 13, 2025, 4:00 PM - Market closed

Acumen Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-116.25-102.33-52.37-42.86-100.61-7.33
Upgrade
Depreciation & Amortization
0.180.180.180.170-
Upgrade
Asset Writedown & Restructuring Costs
--0.74---
Upgrade
Loss (Gain) From Sale of Investments
-3.94-5.11-3.130.490.16-
Upgrade
Stock-Based Compensation
9.639.646.153.060.920.15
Upgrade
Other Operating Activities
-0.45-0.241.51-81.27-0.59
Upgrade
Change in Accounts Receivable
------0.08
Upgrade
Change in Accounts Payable
-2.024.27-0.260.550.560.31
Upgrade
Change in Other Net Operating Assets
10.387.384.133.43-0.260.08
Upgrade
Operating Cash Flow
-102.48-86.22-43.06-35.15-17.96-7.45
Upgrade
Capital Expenditures
-0.08-0.02-0.02-0.16-0.04-
Upgrade
Sale of Property, Plant & Equipment
--0---
Upgrade
Investment in Securities
8648.04-171.6539.35-104.08-
Upgrade
Investing Cash Flow
85.9248.03-171.6739.19-104.12-
Upgrade
Long-Term Debt Issued
--30---
Upgrade
Long-Term Debt Repaid
--0.74----
Upgrade
Net Debt Issued (Repaid)
--0.7430---
Upgrade
Issuance of Common Stock
0.047.94122.233.91169.19-
Upgrade
Repurchase of Common Stock
-0.08-0.04----
Upgrade
Other Financing Activities
-0.17-0.23-0.48---
Upgrade
Financing Cash Flow
-0.226.93151.753.91200.4744.68
Upgrade
Net Cash Flow
-16.77-31.26-62.987.9478.3937.23
Upgrade
Free Cash Flow
-102.56-86.23-43.09-35.31-18-7.45
Upgrade
Free Cash Flow Margin
------518.80%
Upgrade
Free Cash Flow Per Share
-1.70-1.44-0.89-0.87-0.90-17.77
Upgrade
Cash Interest Paid
2.972.970.17---
Upgrade
Levered Free Cash Flow
-63.49-52.29-28.24-20.94-16.350.21
Upgrade
Unlevered Free Cash Flow
-60.93-49.75-27.87-20.94-16.350.21
Upgrade
Change in Net Working Capital
-8.48-11.71-4.03-4.264.99-5
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q